Table 1.
Patient characteristics
| Patient | Progression time: time to metastasis (months) | Age at primary | Tumor size (cm) | Histology | Fuhrman grade | Gender | Metastasis location |
|---|---|---|---|---|---|---|---|
| 1 |
6 |
51 |
5 |
Clear Cell |
3 |
M |
Lung |
| 2 |
72 |
64 |
3.2 |
Clear Cell |
3 |
M |
Lung |
| 3 |
6 |
50 |
10 |
Clear Cell |
3 |
M |
Abdominal Wall |
| 4 |
12 |
45 |
7 |
Clear Cell |
3 |
M |
Skin |
| 5 |
12 |
70 |
4 |
Clear Cell |
2 |
M |
Lung |
| 6 |
6 |
58 |
3 |
Clear Cell |
2 |
F |
Colon |
| 7 |
24 |
17 |
13 |
Clear Cell |
3 |
F |
Lung |
| 8 |
36 |
66 |
4 |
Clear Cell |
2 |
M |
Lung |
| 9 |
24 |
64 |
10.7 |
Clear Cell |
3 |
M |
Liver |
| 10 |
48 |
69 |
6 |
Clear Cell |
3 |
F |
Skin |
| 11 |
36 |
61 |
8 |
Clear Cell |
3 |
F |
Lung |
| 12 |
24 |
61 |
8 |
Clear Cell |
3 |
F |
Liver |
| 13 |
36 |
68 |
4.5 |
Clear Cell |
1 |
M |
Bone |
| 14 |
6 |
56 |
11 |
Clear Cell |
3 |
F |
Pituitary |
| 15 |
120 |
47 |
8 |
Clear Cell |
3 |
M |
Testes |
| 16 |
24 |
54 |
6.5 |
Clear Cell |
2 |
F |
Soft Tissue |
| 17 |
48 |
62 |
10.5 |
Clear Cell |
3 |
M |
Bone |
| 18 |
156 |
56 |
3.5 |
Clear Cell |
3 |
M |
Lung |
| 19 |
108 |
59 |
8.5 |
Clear Cell |
2 |
M |
Lung |
| 20 |
12 |
28 |
4 |
Mixed |
3 |
M |
Lymph Node |
| 21 |
6 |
54 |
Unknown |
Clear Cell |
2 |
M |
Lung |
| 22 |
12 |
40 |
3.7 |
Mixed |
4 |
M |
Lung |
| 23 |
6 |
64 |
3.5 |
Clear Cell |
2 |
M |
Bone |
| 24 |
84 |
46 |
14.5 |
Clear Cell |
2 |
F |
Lung |
| 25 |
36 |
55 |
8.5 |
Clear Cell |
2 |
M |
Lung |
| 26 |
36 |
66 |
6.5 |
Clear Cell |
2 |
M |
Adrenal |
| 27 |
132 |
72 |
5 |
Clear Cell |
2 |
F |
Adrenal |
| 28 |
12 |
72 |
6 |
Mixed |
3 |
F |
Soft Tissue |
| 29 |
6 |
52 |
3.5 |
Clear Cell |
3 |
F |
Bone |
| 30 |
12 |
50 |
12 |
Clear Cell |
2 |
F |
Skin |
| 31 |
6 |
33 |
3.5 |
Clear Cell |
2 |
M |
Bone |
| 32 |
36 |
69 |
10.5 |
Clear Cell |
3 |
F |
Bone |
| 33 |
12 |
62 |
6 |
Clear Cell |
3 |
M |
Bone |
| 34 | 36 | 47 | 8 | Clear Cell | 3 | F | Lung |